Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,248 public trials 542 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Completed

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

NCT00014755

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Washington University Barnard Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Terminated

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

NCT05581199

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Number - 1603 Scottsdale, Arizona, United States
  • Site Number - 1634 Los Angeles, California, United States
  • Site Number - 1625 Aurora, Colorado, United States
  • Site Number - 1621 New Haven, Connecticut, United States
View all 98 locations
View Trial Details
Terminated

An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07188844

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Number - 1621 New Haven, Connecticut, United States
  • Site Number - 1617 Ormond Beach, Florida, United States
  • Site Number - 1611 Nicholasville, Kentucky, United States
  • Site Number - 1610 Charlotte, North Carolina, United States
View all 30 locations
View Trial Details
Terminated

A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

NCT03368664

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Investigational Site Number : 2500001 Le Kremlin-Bicêtre, France
  • Investigational Site Number : 2500002 Strasbourg, France
  • Investigational Site Number : 3800004 Naples, Napoli, Italy
  • Investigational Site Number : 3800005 Cagliari, Italy
View all 13 locations
View Trial Details

Related conditions